Galderma Laboratories, L.P.

Galderma is a global dermatology company headquartered in Fort Worth, TX, specializing in injectable aesthetics, dermatological skincare, and therapeutic dermatology products. The company operates a diverse portfolio of premium brands addressing the full spectrum of dermatological needs across aesthetic and therapeutic applications. Core product lines include injectable aesthetic treatments (Dysport, Restylane, Sculptra, Azzalure), skincare and regenerative products (Cetaphil, ALASTIN, Differin), and therapeutic dermatology medications for conditions including acne, rosacea, and fungal infections (Epiduo Forte, Soolantra, Mirvaso, Oracea, Loceryl, Metvix, Benzac). The company manufactures products meeting regulatory standards and serves dermatologists, aesthetic practitioners, and consumers globally. Galderma emphasizes innovation in regenerative skincare platforms, with recent product launches including formulations with proprietary TriHex Technology. The company maintains manufacturing capabilities and conducts R&D in advancing skincare science. Galderma serves both professional clinical markets and consumer skincare segments, positioning itself as a comprehensive solution provider for diverse skin conditions and aesthetic needs.